1. Home
  2. VYGR vs VRA Comparison

VYGR vs VRA Comparison

Compare VYGR & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.62

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

N/A

Current Price

$5.40

Market Cap

156.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
VRA
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
193.5M
156.6M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
VYGR
VRA
Price
$1.62
$5.40
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $14.22
N/A
AVG Volume (30 Days)
★ 945.7K
494.1K
Earning Date
11-05-2026
12-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.47
EPS
N/A
★ N/A
Revenue
$10,135,000.00
★ $416,097,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$172.11
$3.56
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.48
$1.39
52 Week High
$5.19
$8.36

Technical Indicators

Market Signals
Indicator
VYGR
VRA
Relative Strength Index (RSI) 36.85 37.70
Support Level N/A $2.89
Resistance Level $2.04 $8.36
Average True Range (ATR) 0.15 0.62
MACD 0.01 -0.25
Stochastic Oscillator 16.22 0.00

Price Performance

Historical Comparison
VYGR
VRA

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

Share on Social Networks: